FDA Inspection 1211275 — Raptim Research Pvt. Ltd.
The FDA completed an inspection of Raptim Research Pvt. Ltd. on Apr 28, 2023 in Navi Mumbai. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 28, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Bioanalytical BA/BE